|Articles|April 1, 2020 (Updated: November 15, 2020)
- Pharmaceutical Executive-04-01-2020
- Volume 40
- Issue 4
Pharmaceutical Executive, April 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 6 years ago
HBA's Woman of the Year 2020: A Motivated Missionalmost 6 years ago
Doubling Down on D&Ialmost 6 years ago
COVID-19 Ripple Effects for Pharmaalmost 6 years ago
Prescribing Patterns: How to Get Ahead of the Trendsalmost 6 years ago
There’s No Easing the Price-vs.-Value Debatealmost 6 years ago
Payer Perspectives on Gene Therapy Reimbursementalmost 6 years ago
Covid-19 Pandemic Thrusts Biopharma R&D to Forefrontalmost 6 years ago
Transforming the CIO Role to Embrace Digital Healthalmost 6 years ago
Country Report: The Czech RepublicNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
5
